Schedule 13G ownership disclosure

NextCure Inc

Common Stock, $0.001 par value per share · CUSIP: 65343E207

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Squadron Master Fund LP

    Shares: 271,127.00 · Class: 9.9%

  • Squadron Capital Management LLC

    Shares: 271,127.00 · Class: 9.9%

  • Matthew Sesterhenn

    Shares: 271,127.00 · Class: 9.9%

  • William Blank

    Shares: 271,127.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002050709-26-000005
Form type
SCHEDULE 13G/A
Filer
NextCure, Inc.
CIK
CIK 1661059
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub